A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

ROWLEY, JANET D.·1973·Nature
DOI 10.1038/243290a0

Cited by (1,005)

Items 201–300 of 1,005

  1. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development
    Andreas Burchert, Ying Wang, D Cai, Nikolas C. C. von Bubnoff, Peter Paschka, Sabine Müller‐Brüsselbach, Oliver Gerhard Ottmann, Justus Duyster, Andreas Hochhaus, Andreas Neubauer · 2005 · Leukemia
  2. Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management
    Elias Joseph Jabbour, Hagop M. Kantarjian · 2014 · American Journal of Hematology
  3. Alterations of Ceramide/Sphingosine 1-Phosphate Rheostat Involved in the Regulation of Resistance to Imatinib-induced Apoptosis in K562 Human Chronic Myeloid Leukemia Cells
    Yusuf Baran, Arelis Salas, Can E. Senkal, Ufuk Gündüz, Jacek Bielawski, Lina Marie Obeid, Besim Öğretmen · 2007 · Journal of Biological Chemistry
  4. CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells
    Linhua Jin, Yoko Tabe, Sergej Naumovich Konoplev, Yuanyuan Xu, Clinton E. Leysath, Hongbo Lu, Shinya H Kimura, Akimichi Ohsaka, Rios Mary Beth, L Calvert et al. · 2008 · Molecular Cancer Therapeutics
  5. Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment
    Su Chu, Helen Xu, Neil P. Shah, DS Snyder, Stephen J. Forman, Charles L. Sawyers, Ravi Bhatia · 2004 · Blood
  6. A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
    Kathleen N. S. Cathcart, Javier A. Pinilla-Ibarz, Tatyana Korontsvit, Joseph E. Schwartz, Victoriya Zakhaleva, Esperanza Bouza Papadopoulos, David A. Scheinberg · 2003 · Blood
  7. The Origin and Development of Human Tumors Studied with Cell Markers
    Philip J. Fialkow · 1974 · New England Journal of Medicine
  8. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis
    Simona Taverna, Anna Maria Flugy, Laura Saieva, Elise C. Kohn, Alessandra Santoro, Serena Meraviglia, Giacomo De Leo, Riccardo Alessandro · 2011 · International Journal of Cancer
  9. The Mll–AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis
    C.L. Dobson, A.J. Warren, R. Pannell, A. Forster, I. Lavenir, Javier Corral, A.J.H. Smith, Terence Howard Rabbitts · 1999 · The EMBO Journal
  10. Clustering of aberrations to specific chromosomes in human neoplasms
    Göran Levan, Felix Mitelman · 2009 · Hereditas
  11. Molecular mechanisms of transformation by the BCR-ABL oncogene
    Martin Sattler, James D. Griffin · 2003 · Seminars in Hematology
  12. Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol)
    Isabel B. Cunningham, T Gee, Monroe D. Dowling, R. S. K. CHAGANTI, Roller B. Bailey, Seymour Hopfan, L Bowden, Alan D. Turnbull, W Knapper, B Clarkson · 1979 · Blood
  13. Advances in Understanding and Management of Myeloproliferative Neoplasms
    Alessandro Maria Vannucchi, Paola Guglielmelli, Ayalew Tefferi · 2009 · CA A Cancer Journal for Clinicians
  14. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
    Robert Peter Gale, Eli Canaani · 1984 · Proceedings of the National Academy of Sciences
  15. Recurrent chimeric fusion RNAs in non-cancer tissues and cells
    Mihaela Babiceanu, Fujun Qin, Zhongqiu Xie, Yuemeng Jia, Kevin Lopez, Nick Janus, Loryn Facemire, Shailesh Kumar, Yuwei Pang, Yanjun Qi et al. · 2016 · Nucleic Acids Research
  16. Altered Transcription of the c- abl Oncogene in K-562 and Other Chronic Myelogenous Leukemia Cells
    Steven John Collins, Ichiro Kubonishi, Isao Miyoshi, Mark T. Groudine · 1984 · Science
  17. STI571: A Paradigm of New Agents for Cancer Therapeutics
    Michael J. Mauro · 2002 · Journal of Clinical Oncology
  18. Chronic myeloid leukaemia
    Jorge Cortes, Carolina Pavlovsky, Susanne Saußele · 2021 · The Lancet
  19. Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias
    Schmidt, Manuel, Nagel, Stefan, Proba, Jutta, Thiede, Christian, Ritter, Markus, Waring, Jeffrey F., Rosenbauer, Frank, Huhn, Dieter, Wittig, Burghardt, Horak, Ivan et al. · 1998 · Blood
  20. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism
    Stefania Raimondo, Laura Saieva, Chiara Corrado, Simona Fontana, Anna Maria Flugy, Aroldo Gabriele Rizzo, Giacomo De Leo, Riccardo Alessandro · 2015 · Cell Communication and Signaling
  21. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry
    Tim H. Brümmendorf, Tessa L. Holyoake, Nathalie Rufer, Michael J. Barnett, Michael Schulzer, Connie J. Eaves, Allen C. Eaves, Peter M. Lansdorp · 2000 · Blood
  22. BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia
    Charles Alan Schiffer · 2007 · New England Journal of Medicine
  23. The Chronic Myelocytic Cell Line K562 Contains a Breakpoint in bcr and Produces a Chimeric bcr/c-abl Transcript
    Gerard C. Grosveld, Theo C. Verwoerd, Ton van Agthoven, Annelies de Klein, K L Ramachandran, Nora Heisterkamp, K Stam, John Groffen · 1986 · Molecular and Cellular Biology
  24. Molecular analysis of mbcl-2: Structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma
    Massimo Negrini, Enrico Maria Silini, Christine A. Kozak, Yoshihide Tsujimoto, Carlo Maria Croce · 1987 · Cell
  25. Differential DNA repair in transcriptionally active and inactive proto-oncogenes: c-abl and c-mos
    Hiten D. Madhani, Vilhelm A. Bohr, Philip C. Hanawalt · 1986 · Cell
  26. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies
    Ramon Velasquez Tiu, Lukasz P. Gondek, Christine L. O’Keefe, Paul J. Elson, Jungwon Huh, Azim M. Mohamedali, Austin Gladston Kulasekararaj, Anjali S. Advani, RONALD L. PAQUETTE, Alan F. List et al. · 2011 · Blood
  27. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells
    GL Nichols, MA Raines, JC Vera, Lynne Lacomis, Paul Tempst, David W. Golde · 1994 · Blood
  28. Ph1-Positive Leukaemia, Including Chronic Myelogenous Leukaemia
    Janet D. Rowley · 1980 · Clinics in Haematology
  29. Chromosome Translocation, B Cell Lymphoma, and Activation-Induced Cytidine Deaminase
    Davide F. Robbiani, Michel C. Nussenzweig · 2012 · Annual Review of Pathology Mechanisms of Disease
  30. Cancer Vaccines, Adjuvants, and Delivery Systems
    Paston, Samantha J., Brentville, Victoria A., Symonds, Peter, Durrant, Lindy G. · 2021 · Frontiers in Immunology
  31. Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia
    Richard Thomas Williams, Martine F. Roussel, Charles J. Sherr · 2006 · Proceedings of the National Academy of Sciences
  32. High Level Engraftment of NOD/SCID Mice by Primitive Normal and Leukemic Hematopoietic Cells From Patients With Chronic Myeloid Leukemia in Chronic Phase
    Jean C. Y. Wang, Tsvee Lapidot, JD Cashman, Monica Doedens, L. Addy, D. Robert Sutherland, Rakesh Nayar, P. Laraya, Mark David Minden, Armand Keating et al. · 1998 · Blood
  33. Cytological and cytogenetical studies on brain tumors
    Heinrich Zankl, K. D. Zang · 1972 · Human Genetics
  34. Evolution of the cancer genome
    Podlaha, Ondrej, Riester, Markus, De, Subhajyoti, Michor, Franziska · 2012 · Trends in Genetics
  35. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia
    Qingfei Jiang, Leslie A. Crews, Christian L. Barrett, Hye-Jung E. Chun, Angela C. Court, Jane Marie Isquith, M Zipeto, Daniel Jacob Goff, Mark David Minden, Anil Sadarangani et al. · 2012 · Proceedings of the National Academy of Sciences
  36. STAT5 Activation by BCR-Abl Contributes to Transformation of K562 Leukemia Cells
    Rolf P. de Groot, Jan A. M. Raaijmakers, Jan‐Willem J. Lammers, Richard Jove, Leo Koenderman · 1999 · Blood
  37. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
    Meir Wetzler, Moshe Talpaz, Richard A. Van Etten, Cheryl Hirsch‐Ginsberg, Miloslav Beran, Razelle Kurzrock · 1993 · Journal of Clinical Investigation
  38. PROTACs to address the challenges facing small molecule inhibitors
    Pedro Martín-Acosta, Xiangshu Xiao · 2020 · European Journal of Medicinal Chemistry
  39. Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein
    Marcus Järås, Petra Johnels, Nils Hansen, Helena Ågerstam, Panagiotis Tsapogas, Marianne Rissler, Carin Lassen, Tor Olofsson, Ole Weis Bjerrum, Johan Richter et al. · 2010 · Proceedings of the National Academy of Sciences
  40. Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century
    Samuel A. Williams, Wade C. Anderson, Marianne T. Santaguida, Scott J. Dylla · 2013 · Laboratory Investigation
  41. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages
    Miron Prokocimer, Varda Rotter · 1994 · Blood
  42. Expanding the computational toolbox for mining cancer genomes
    Li Ding, Michael C. Wendl, Joshua F. McMichael, Benjamin J. Raphael · 2014 · Nature Reviews Genetics
  43. Chromatin structural elements and chromosomal translocations in leukemia
    Yanming Zhang, Janet D. Rowley · 2006 · DNA repair
  44. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring
    Elias Joseph Jabbour, Hagop M. Kantarjian · 2016 · American Journal of Hematology
  45. Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future
    Valentina R. Minciacchi, Rahul Kumar, Daniela S. Krause · 2021 · Cells
  46. The Cytogenetic Scenario of Chronic Myeloid Leukemia
    Felix Mitelman · 1993 · Leukemia & lymphoma/Leukemia and lymphoma
  47. Chromosomal translocations in cancer
    Mridula Nambiar, Vijayalakshmi Kari, Sathees C. Raghavan · 2008 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  48. Translocation renal cell carcinoma
    James I. Geller, Pedram Argani, Adebowale Adeniran, Edith Hampton, Angelo De Marzo, Jessica L Hicks, Margaret H. Collins · 2008 · Cancer
  49. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity
    William S. Kloetzer, Razelle Kurzrock, Lynda Smith, Moshe Talpaz, Margery Spiller, Jordan U. Gutterman, Ralph B. Arlinghaus · 1985 · Virology
  50. Generation of phenotypic diversity and progression in metastatic tumor cells
    Garth L. Nicolson · 1984 · Cancer and Metastasis Reviews
  51. Stem cells in prostate cancer initiation and progression.
    Devon A. Lawson, O. Witte · 2007 · Journal of Clinical Investigation
  52. Ablation of Fbxw7 Eliminates Leukemia-Initiating Cells by Preventing Quiescence
    Shoichiro Takeishi, Akinobu Matsumoto, Ichiro Onoyama, Kazuhito Naka, Atsushi Hirao, Keiichi I. Nakayama · 2013 · Cancer Cell
  53. BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
    Christian Hurtz, Katerina Hatzi, Leandro C. A. Cerchietti, Melanie Braig, Eugene Park, Yong‐Mi Kim, Sebastian Herzog, Parham Ramezani-Rad, Hassan Jumaa, Martin C. Müller et al. · 2011 · The Journal of Experimental Medicine
  54. Recurrent read-through fusion transcripts in breast cancer
    Katherine Elena Varley, Jason Gertz, Brian S. Roberts, Nicholas S. Davis, Kevin M. Bowling, Marie K. Kirby, Amy S. Nesmith, Patsy G. Oliver, William E. Grizzle, Andres Forero et al. · 2014 · Breast Cancer Research and Treatment
  55. Myeloproliferative neoplasms: A decade of discoveries and treatment advances
    Ayalew Tefferi · 2015 · American Journal of Hematology
  56. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Miloslav Beran, Xuanye Cao, Zeev Estrov, Sima Jeha, Guang Jin, Susan Mary O'Brien, Moshe Talpaz, Ralph B. Arlinghaus, Nicholas Lydon, Hagop M. Kantarjian · 1998 · PubMed
  57. Kinome-wide Decoding of Network-Attacking Mutations Rewiring Cancer Signaling
    Pau Creixell, Erwin M. Schoof, Craig D. Simpson, James Longden, Chad J. Miller, Hua Jane Lou, Lara Perryman, Thomas R. Cox, Nevena Zivanovic, Antonio Palmeri et al. · 2015 · Cell
  58. Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities
    Evelin Schröck, Timothy Veldman, Hesed M. Padilla‐Nash, Yi Ning, Jack L. Spurbeck, Syed M. Jalal, Lisa G. Shaffer, Peter R. Papenhausen, Chahira Kozma, Mary C. Phelan et al. · 1997 · Human Genetics
  59. The BCR-ABL Oncogene Transforms Rat-1 Cells and Cooperates with v- myc
    TRACY GROSS LUGO, Owen N. Witte · 1989 · Molecular and Cellular Biology
  60. Chromosome Abnormalities in Malignant Hematologic Diseases
    Janet D. Rowley, Joseph R. Testa · 1982 · Advances in cancer research
  61. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an Interleukin 8-dependent survival of leukemia cells
    Chiara Corrado, Stefania Raimondo, Laura Saieva, Anna Maria Flugy, Giacomo De Leo, Riccardo Alessandro · 2014 · Cancer Letters
  62. Inversion of chromosome 14 marks human T-cell chronic lymphocytic leukaemia
    Lore Zech, Gösta Gahrton, Lennart L G Hammarström, Gunnar Juliusson, Håkan Mellstedt, K.‐H. ROBÈRT, C. I. E. Smith · 1984 · Nature
  63. Nilotinib: A second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia
    DeRemer, David L., Ustun, Celalettin, Natarajan, Kavita · 2008 · Clinical Therapeutics
  64. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications
    George Adrian Calin, Carlo Maria Croce · 2007 · Journal of Clinical Investigation
  65. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells
    Ruhong Li, George Yerganian, PETER H. DUESBERG, Alwin Kraemer, Andreas Willer, Charlotte Rausch, Rüediger Hehlmann · 1997 · Proceedings of the National Academy of Sciences
  66. The First Intron in the Human c- abl Gene Is at Least 200 Kilobases Long and Is a Target for Translocations in Chronic Myelogenous Leukemia
    André Bernards, C M Rubin, C A Westbrook, Michael P. Paskind, David Baltimore · 1987 · Molecular and Cellular Biology
  67. Trial watch
    Erika Vacchelli, Isabelle Martins, Alexander M.M. Eggermont, Wolf H. Fridman, Jérôme Galon, Catherine Sautès‐Fridman, Éric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi · 2012 · OncoImmunology
  68. Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells
    Julian Topaly, Zeller Wj, Stefan Früehauf · 2001 · Leukemia
  69. BCR/ABL induces multiple abnormalities of cytoskeletal function.
    Ravi Salgia, Jian‐Liang Li, Darren S. Ewaniuk, Warren S. Pear, Evan P. Pisick, Stephen A. Burky, T J Ernst, Martin Sattler, L B Chen, James D. Griffin · 1997 · Journal of Clinical Investigation
  70. The JAK2 exon 12 mutations: A comprehensive review
    Linda M. Scott · 2011 · American Journal of Hematology
  71. Translating cancer genomes and transcriptomes for precision oncology
    Sameek Roychowdhury, Arul M. Chinnaiyan · 2015 · CA A Cancer Journal for Clinicians
  72. Trisomy of chromosome 15 in spontaneous leukemia of AKR mice.
    Ryuichi Dofuku, June L. Biedler, Barbara A. Spengler, Lloyd J. Old · 1975 · Proceedings of the National Academy of Sciences
  73. The Nature of Chromosomal Aberrations Detected in Humans Exposed to Benzene
    Luoping Zhang, David A. Eastmond, Martyn T. Smith · 2002 · Critical Reviews in Toxicology
  74. Somatic alterations in the human cancer genome
    Barbara A. Weir, Xiaojun Zhao, Matthew M. Meyerson · 2004 · Cancer Cell
  75. Apoptosis and Cancer
    Anthony G. Letai · 2016 · Annual Review of Cancer Biology
  76. The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia
    Lars Klemm, Cihangir Duy, Ilaria Iacobucci, Stefan Kuchen, Gregor von Levetzow, Niklas Feldhahn, Nadine Henke, Zhiyu Li, Thomas Karl Hoffmann, Yong‐Mi Kim et al. · 2009 · Cancer Cell
  77. BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells
    Su Chu, Melissa S. Holtz, Mamta Gupta, Ravi Bhatia · 2003 · Blood
  78. Chronic myelogenous leukemia: mechanisms underlying disease progression
    Arun S. Shet, Balkrishna Jahagirdar, Catherine M. Verfaillie · 2002 · Leukemia
  79. The CML-Specific P210 bcr / abl Protein, Unlike v- abl , Does Not Transform NIH/3T3 Fibroblasts
    George Q. Daley, Jami McLaughlin, Owen N. Witte, David Baltimore · 1987 · Science
  80. Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583 [see comments]
    H Ozer, SL George, CA Schiffer, K Rao, P. Nagesh Rao, DH Wurster-Hill, D C Arthur, Byron J. Powell, Arlan J. Gottlieb, BA Peterson · 1993 · Blood
  81. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes
    Terence Howard Rabbitts · 1998 · Genes & Development
  82. A Novel SH2-Containing Phosphatidylinositol 3,4,5-Trisphosphate 5-Phosphatase (SHIP2) Is Constitutively Tyrosine Phosphorylated and Associated With src Homologous and Collagen Gene (SHC) in Chronic Myelogenous Leukemia Progenitor Cells
    Wisniewski, David, Strife, Annabel, Swendeman, Steve, Erdjument-Bromage, Hediye, Geromanos, Scott, Kavanaugh, W. Michael, Tempst, Paul, Clarkson, Bayard · 1999 · Blood
  83. Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.
    David John Wisniewski, Caryl L Lambek, Chongyuan Liu, Annabel Strife, Darren R. Veach, Bhushan Nagar, Matthew Adam Young, Thomas Hellmut Schindler, William G. Bornmann, Joseph R. Bertino et al. · 2002 · PubMed
  84. Chronic myelogenous leukemia: A review
    Jörge E. Cortes, Moshe Talpaz, Hagop M. Kantarjian · 1996 · The American Journal of Medicine
  85. Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias
    Siddhartha Jaiswal, David J. Traver, Toshihiro Miyamoto, Koichi Akashi, Eric Lagasse, Irving L. Weissman · 2003 · Proceedings of the National Academy of Sciences
  86. Chronic Myeloid Leukemia
    Junia V. Melo, Timothy P. Hughes, Jane F. Apperley · 2003 · Hematology
  87. Further evidence for a non‐random chromosomal abnormality in acute promyelocytic leukemia
    Janet D. Rowley, Harvey M. Golomb, James W. Vardiman, Shirou Fukuhara, Charlotte P. Dougherty, David A. Potter · 1977 · International Journal of Cancer
  88. Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches
    Haley Abel, Eric J. Duncavage · 2013 · Cancer Genetics
  89. Cancer genetics
    Alfred G. Knudson · 2002 · American Journal of Medical Genetics
  90. Initiation of Deregulated Growth of Multipotent Progenitor Cells by bcr-abl in Vitro
    Mikhail L. Gishizky, Owen N. Witte · 1992 · Science
  91. Chromosome 14 translocations in non‐burkitt lymphomas
    Shirou Fukuhara, Janet D. Rowley · 1978 · International Journal of Cancer
  92. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
    HG Ahuja, Menashe Bar‐Eli, Z. A. Arlin, S H Advani, Steven L. Allen, John M. Goldman, DS Snyder, A Foti, Martin J. Cline · 1991 · Journal of Clinical Investigation
  93. Oncogenes in Myeloproliferative Disorders
    Ayalew Tefferi, Dwight Gary Gilliland · 2007 · Cell Cycle
  94. Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway
    Ruth Naughton, Claire Quiney, Suzanne Dawn Turner, Thomas G. Cotter · 2009 · Leukemia
  95. Nephrotoxicity in cancer treatment: An overview
    Maria Luísa Cordeiro Santos, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Anelise Costa dos Santos Botelho, Fabrício Freire de Melo · 2020 · World Journal of Clinical Oncology
  96. Mechanisms involved in the induced differentiation of leukemia cells
    Asterios S. Tsiftsoglou, Ioannis S. Pappas, Ioannis S. Vizirianakis · 2003 · Pharmacology & Therapeutics
  97. Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors
    Preetesh Jain, Hagop M. Kantarjian, Keyur Pravinchandra Patel, Graciela Nogueras González, Rajyalakshmi Luthra, Rashmi Kanagal‐Shamanna, Koji Sasaki, Elias Joseph Jabbour, Carlos Guillermo Romo, Tapan Mahendra Kadia et al. · 2016 · Blood
  98. Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation?
    A Hagemeijer, CR Bartram, E.M.E. Smit, André Van Agthoven, D. Bootsma · 1984 · Cancer Genetics and Cytogenetics
  99. Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML
    Warfvinge, Rebecca, Geironson, Linda, Sommarin, Mikael N. E., Lang, Stefan, Karlsson, Christine, Roschupkina, Teona, Stenke, Leif, Stentoft, Jesper, Olsson-Strömberg, Ulla, Hjorth-Hansen, Henrik et al. · 2017 · Blood
  100. Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Kathrin Maria Bernt, Stephen P. Hunger · 2014 · Frontiers in Oncology